Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Narrative review: mesenchymal-epithelial transition inhibitors-meeting their target. | Transl Lung Cancer Res | 2021 | 33569327 | PubTator, text mining | PubMed |
| TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients. | Cancers (Basel) | 2021 | 33546249 | PubTator, text mining | PubMed |
| Development and verification of an immune-related gene pairs prognostic signature in ovarian cancer. | J Cell Mol Med | 2021 | 33543590 | PubTator, text mining | PubMed |
| The role of MET in chemotherapy resistance. | Oncogene | 2021 | 33526881 | PubTator, text mining | PubMed |
| Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling. | Cancer Lett | 2021 | 33508385 | PubTator, text mining | PubMed |
| Comprehensive Review on the Clinical Relevance of Long Non-Coding RNAs in Cutaneous Melanoma. | Int J Mol Sci | 2021 | 33503876 | PubTator, text mining | PubMed |
| Co-Overexpression of TWIST1-CSF1 Is a Common Event in Metastatic Oral Cancer and Drives Biologically Aggressive Phenotype. | Cancers (Basel) | 2021 | 33466385 | PubTator, text mining | PubMed |
| Research trends in pharmacological modulation of tumor-associated macrophages. | Clin Transl Med | 2021 | 33463063 | PubTator, text mining | PubMed |
| Biological constraints on GWAS SNPs at suggestive significance thresholds reveal additional BMI loci. | Elife | 2021 | 33459256 | PubTator, text mining | PubMed |
| Novel Tyrosine Kinase Targets in Urothelial Carcinoma. | Int J Mol Sci | 2021 | 33451055 | PubTator, text mining | PubMed |
| Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis. | Sci Rep | 2021 | 33420337 | PubTator, text mining | PubMed |
| Dose adjustment for tyrosine kinase inhibitors in non‑small cell lung cancer patients with hepatic or renal function impairment (Review). | Oncol Rep | 2021 | 33416184 | PubTator, text mining | PubMed |
| Recepteur d'origine nantais contributes to the development of endometriosis via promoting epithelial-mesenchymal transition of a endometrial epithelial cells. | J Cell Mol Med | 2021 | 33410267 | PubTator, text mining | PubMed |
| Nanomedicine of tyrosine kinase inhibitors. | Theranostics | 2021 | 33408767 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| Understanding the unimodal distributions of cancer occurrence rates: it takes two factors for a cancer to occur. | Brief Bioinform | 2021 | 33377150 | PubTator, text mining | PubMed |
| Systemic Therapies for the Management of Non-Clear Cell Renal Cell Carcinoma: What Works, What Doesn't, and What the Future Holds. | Clin Genitourin Cancer | 2021 | 33358151 | PubTator, text mining | PubMed |
| The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials. | Drug Deliv | 2021 | 33336610 | PubTator, text mining | PubMed |
| RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. | Br J Cancer | 2021 | 33257837 | PubTator, text mining | PubMed |
| Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo. | Oncogene | 2021 | 33235291 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=29